Assenagon Asset Management S.A. 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 06:15 am Sale |
2022-01-14 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 0 0.000% |
-475,856 (Position Closed) |
Filing |
| 2022-01-18 06:12 am Purchase |
2022-01-13 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 475,856 5.980% |
193,267 (+68.39%) |
Filing |
| 2020-08-06 11:13 am Purchase |
2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 282,589 6.390% |
222,819 (+372.79%) |
Filing |
| 2020-08-06 11:13 am Purchase |
2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 59,771 1.070% |
59,771 (New Position) |
Filing |
| 2020-06-19 10:20 am Sale |
2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 59,771 1.070% |
-222,819 (-78.85%) |
Filing |
| 2020-06-19 10:18 am Purchase |
2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO |
Assenagon Asset Management S.A. | 282,589 6.390% |
282,589 (New Position) |
Filing |